Comparison of Risk of Osteoporotic Fracture in Denosumab vs Alendronate Treatment Within 3 Years of Initiation.
JAMA Netw Open. 2019 Apr 5;2(4):e192416. doi:10.1001/jamanetworkopen.2019.2416. Pedersen AB, Heide-Jørgensen U, Sørensen HT, Prieto-Alhambra D, Ehrenstein V.